Kymera Therapeutics Inc. Common Stock vs Victoria's Secret & Co — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Victoria's Secret & Co trades at $88 (market cap $7.05B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| KYMR | VSXY | |
|---|---|---|
Market Cap | $8.88B | $7.05B |
Volume | 1,028,790 | 1,022,828 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $99.97 |
52-Week Low | $55.80 | $30.19 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $8.27B | $9.43B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →